Spermidine synthase Rabbit Polyclonal Antibody (BF350)
Spermidine synthase Rabbit Polyclonal Antibody (BF350) is a BF350 conjugated antibody targeting SRM. This antibody is suitable for ICC, IF.
Product Specifications
Product Name Alternative
OTTHUMP00000002170; PAPT; Putrescine aminopropyltransferase; SPDSY; SPEE_HUMAN; Spermidine synthase 1; Spermidine synthase; SPS1; Srm; SRML1.
Immunogen
KLH conjugated synthetic peptide derived from human Spermidine synthase (131-230/302aa)
Target
SRM
Clonality
Polyclonal
Conjugation
BF350
Field of Research
Metabolism Research
Purification
Affinity purified by Protein A
Concentration
1mg/ml
Dilution
ICC/IF=1:50-200, IF=1:100-500
Storage Conditions
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Notes
For research use only.
Prediction Reactivity
Human
Tested Applications
ICC, IF
Host or Source
Rabbit
Preservative
0.01M TBS (pH7.4) with 1% rAlbumin, 0.02% Proclin300 and 50% Glycerol.
Isotype
IgG
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
QT-EH4530 96 Tests
Human RNF-111 (E3 ubiquitin-protein ligase Arkadia) QuickTest ELISA Kit
Sign In for Pricing
View Details 
124863-ML550 100 µL
CEP250 (Centrosome-associated Protein CEP250, 250kD Centrosomal Protein, Cep250, Centrosomal Nek2-associated Protein 1, C-Nap1, Centrosomal Protein 2, CEP2, CNAP1) (MaxLight 550)
Sign In for Pricing
View Details MBS6346120-01 0.2 mL
SEPSECS, CT (SEPSECS, TRNP48, O-phosphoseryl-tRNA(Sec) selenium transferase, Liver-pancreas antigen, SLA-p35, SLA/LP autoantigen, Selenocysteine synthase, Selenocysteinyl-tRNA(Sec) synthase, Sep-tRNA:Sec-tRNA synthase, Soluble liver antigen, UGA suppresso
Sign In for Pricing
View Details MBS6346120-02 5x 0.2 mL
SEPSECS, CT (SEPSECS, TRNP48, O-phosphoseryl-tRNA(Sec) selenium transferase, Liver-pancreas antigen, SLA-p35, SLA/LP autoantigen, Selenocysteine synthase, Selenocysteinyl-tRNA(Sec) synthase, Sep-tRNA:Sec-tRNA synthase, Soluble liver antigen, UGA suppresso
Sign In for Pricing
View Details 